BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11043934)

  • 1. Molecular modeling of the interactions of trichosanthin with four substrate analogs.
    Gu Y; Chen W; Xia Z
    J Protein Chem; 2000 May; 19(4):291-7. PubMed ID: 11043934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structures of the complexes of trichosanthin with four substrate analogs and catalytic mechanism of RNA N-glycosidase.
    Gu YJ; Xia ZX
    Proteins; 2000 Apr; 39(1):37-46. PubMed ID: 10737925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substrate binding and catalysis in trichosanthin occur in different sites as revealed by the complex structures of several E85 mutants.
    Guo Q; Zhou W; Too HM; Li J; Liu Y; Bartlam M; Dong Y; Wong KB; Shaw PC; Rao Z
    Protein Eng; 2003 Jun; 16(6):391-6. PubMed ID: 12874371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of TYR70 in the N-glycosidase activity of neo-trichosanthin.
    Yan L; Wu S; Li HG; Li JH; Wong RN; Shi QL; Dong YC
    Toxicon; 1999 Jul; 37(7):961-72. PubMed ID: 10484744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescence spectroscopic study of the interaction of adenine and nucleotide with trichosanthin.
    Hao Q; Zhang Y; Yang H; Liu G; Huang Z; Liu B; Yao Q; Li Q
    Biochem Mol Biol Int; 1995 Jul; 36(4):889-95. PubMed ID: 8528152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mechanism of action of trichosanthin on eukaryotic ribosomes--RNA N-glycosidase activity of the cytotoxin.
    Zhang JS; Liu WY
    Nucleic Acids Res; 1992 Mar; 20(6):1271-5. PubMed ID: 1561083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The structural basis of Trp192 and the C-terminal region in trichosanthin for activity and conformational stability.
    Ding Y; Too H; Wang Z; Liu Y; Bartlam M; Dong Y; Wong K; Shaw P; Rao Z
    Protein Eng; 2003 May; 16(5):351-6. PubMed ID: 12826726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between trichosanthin, a ribosome-inactivating protein, and the ribosomal stalk protein P2 by chemical shift perturbation and mutagenesis analyses.
    Chan DS; Chu LO; Lee KM; Too PH; Ma KW; Sze KH; Zhu G; Shaw PC; Wong KB
    Nucleic Acids Res; 2007; 35(5):1660-72. PubMed ID: 17308345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and Functional Investigation and Pharmacological Mechanism of Trichosanthin, a Type 1 Ribosome-Inactivating Protein.
    Shi WW; Wong KB; Shaw PC
    Toxins (Basel); 2018 Aug; 10(8):. PubMed ID: 30127254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solution structure of human P1•P2 heterodimer provides insights into the role of eukaryotic stalk in recruiting the ribosome-inactivating protein trichosanthin to the ribosome.
    Lee KM; Yusa K; Chu LO; Yu CW; Oono M; Miyoshi T; Ito K; Shaw PC; Wong KB; Uchiumi T
    Nucleic Acids Res; 2013 Oct; 41(18):8776-87. PubMed ID: 23892290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Change in pH-dependent membrane insertion characteristics of trichosanthin caused by deletion of its last seven C-terminal amino acid residues.
    Zhang F; Lu YJ; Shaw PC; Sui SF
    Biochemistry (Mosc); 2003 Apr; 68(4):436-45. PubMed ID: 12765527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trichosanthin interacts with acidic ribosomal proteins P0 and P1 and mitotic checkpoint protein MAD2B.
    Chan SH; Hung FS; Chan DS; Shaw PC
    Eur J Biochem; 2001 Apr; 268(7):2107-12. PubMed ID: 11277934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of trichosanthin at 1.88 A resolution.
    Zhou K; Fu Z; Chen M; Lin Y; Pan K
    Proteins; 1994 May; 19(1):4-13. PubMed ID: 8066085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Research on ribosome-inactivating proteins from angiospermae to gymnospermae and cryptogamia.
    Liu WY
    Am J Transl Res; 2017; 9(12):5719-5742. PubMed ID: 29312524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Sixty-Year Research and Development of Trichosanthin, a Ribosome-Inactivating Protein.
    Lu JQ; Wong KB; Shaw PC
    Toxins (Basel); 2022 Feb; 14(3):. PubMed ID: 35324675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The C-terminal fragment of the ribosomal P protein complexed to trichosanthin reveals the interaction between the ribosome-inactivating protein and the ribosome.
    Too PH; Ma MK; Mak AN; Wong YT; Tung CK; Zhu G; Au SW; Wong KB; Shaw PC
    Nucleic Acids Res; 2009 Feb; 37(2):602-10. PubMed ID: 19073700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystallization and preliminary x-ray crystallographic studies of trichosanthin delta C7.
    Li X; Ding Y; Wang Z; Liu Y; Dong Y; Shaw P; Rao Z; Too H
    Protein Pept Lett; 2002 Jun; 9(3):269-73. PubMed ID: 12144525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-density lipoprotein receptor-related protein 1 is an essential receptor for trichosanthin in 2 choriocarcinoma cell lines.
    Jiao Y; Liu W
    Biochem Biophys Res Commun; 2010 Jan; 391(4):1579-84. PubMed ID: 19968964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced green fluorescence protein tracks trichosanthin in human choriocarcinoma cells as a feasible and stable reporter.
    Wang Y; Mi SL; Lou MY; Gao Y; Chen ZL; An CC
    Front Biosci; 2005 Sep; 10():2279-84. PubMed ID: 15970494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-HIV agent trichosanthin enhances the capabilities of chemokines to stimulate chemotaxis and G protein activation, and this is mediated through interaction of trichosanthin and chemokine receptors.
    Zhao J; Ben LH; Wu YL; Hu W; Ling K; Xin SM; Nie HL; Ma L; Pei G
    J Exp Med; 1999 Jul; 190(1):101-11. PubMed ID: 10429674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.